[1] 瞬时弹性成像技术(TE)临床应用共识专家委员会. 瞬时弹性成像技术(TE)临床应用专家共识(2015年). 中国肝脏病杂志(电子版),2015,7:12-18.
[2] 钤培国,廉晓晓,郭晓霞. 无创诊断模型诊断乙型肝炎和肝硬化患者肝纤维化价值评价. 实用肝脏病杂志,2016,19:578-582.
[3] Lee HW,Kang W,Kim BK,et al. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B.Liver Int. 2016,36:24-30.
[4] Kim WR,Berg T,Asselah T,et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol,2016,64:773-780.
[5] 王晓霞,邹正升,李保森,等. 2002至2011年中国“北方”地区住院肝硬化患者病因构成及变化趋势分析. 实用肝脏病杂志,2014,17:154-158.
[6] 陈士林,孟晓丹,王炳元,等. 辽宁省部分城市酒精性肝病流行现状调查. 实用肝脏病杂志,2010,13:428-430.
[7] 李建生,刘文斌. 肝炎肝硬化门脉高压症的治疗现状. 实用肝脏病杂志,2006,9:375-377.
[8] Lakatos LP,Bajnok E,Hegedus D,et al. Vitamin D receptor,oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol,2002,14:733-740.
[9] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015). 肝脏,2015,20:960-968.
[10] 王炳元,高君. 重视酒精性肝病的诊断与治疗. 北京医学,2014,36:206-207.
[11] Ohtsuka T,Tsutsumi M,Fukumura A,et al. Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from nonalcoholic steatohepatitis:a pilot study. Alcohol Clin Exp Res,2005,29:236S-239S.
[12] 陈焕永,姜宏齐,邵凤娟. γ-谷氨酰转肽酶与各种肝病关系初探. 哈尔滨医科大学学报,2003,37:346-347.
[13] Gressner OA,Weiskirchen R,Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta,2007,381:107-113.
[14] Naveau S, Raynard B, Ratziu V,et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol,2005,3:167-174.
[15] Usluer G,Erben N,Aykin N,et al. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C. Eur J Clin Microbiol Infect Dis, 2012,31:1873-1878. |
